Thursday, July 9, 2026

Drug profile · INN

technetium tc-99m disofenin kit

technetium tc-99m disofenin kit (HEPATOLITE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — technetium tc-99m disofenin kit
US status
approved
Class
Route
INJECTION
Patents
0
Programs
3
Data quality
0.84

Quick answer

technetium tc-99m disofenin kit (HEPATOLITE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN technetium tc-99m disofenin kit
Brand HEPATOLITE
Route INJECTION
Formulation INJECTABLE

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. SOF Phase 3 · Sunshine Guojian Pharmaceutical · Chronic HCV Infection
  2. SOF Phase 2 · Gilead Sciences Ireland · Hepatitis C Virus Infection
  3. SOF Phase 2 · Gilead Sciences Ireland · HCV Infection

Frequently asked questions

What is technetium tc-99m disofenin kit?

technetium tc-99m disofenin kit (HEPATOLITE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for technetium tc-99m disofenin kit?

HEPATOLITE is a marketed brand name for technetium tc-99m disofenin kit. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of technetium tc-99m disofenin kit?

technetium tc-99m disofenin kit has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.